Walpar Nutritions Limited — Results, 13-11-2025: Integrated Filing- Financial

Walpar Nutritions posted solid financial results for the half-year ended Sept 30, 2025.

1. **Financial Performance:** Total revenue grew 11.5% YoY to ₹36.62 Cr, driven by its core pharmaceutical, nutraceutical, herbal, and ayurvedic business.

2. **Profitability and EPS:** Net profit attributable to owners remained nearly flat YoY at ₹1.29 Cr. Earnings Per Share (EPS) also saw minimal change at ₹1.38.

3. **Growth Drivers & Expense Trends:** Strong revenue growth was notably impacted by rising costs. Employee benefit expenses surged almost 50% YoY, alongside increased finance and material costs.

4. **Final Lens for Investors:** These results indicate mixed financial momentum, with robust top-line growth partially absorbed by higher operational expenses.